Table of Contents

FREE CONTENT FROM ASM  AUTHOR-SPONSORED OPEN ACCESS  

Vaccines

  • Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Vectors Efficiently Prime SIV-Specific Systemic and Mucosal Immune Responses by Targeting Myeloid Dendritic Cells and Persisting in Rectal Macrophages, Regardless of Immunization Route

    • L. Jean Patterson,
    • Seraphin Kuate,
    • Mara Daltabuit-Test,
    • Qingsheng Li,
    • Peng Xiao,
    • Katherine McKinnon,
    • Janet DiPasquale,
    • Anthony Cristillo,
    • David Venzon,
    • Ashley Haase,
    • and Marjorie Robert-Guroff
    Clin. Vaccine Immunol. May 2012 19:629-637; published ahead of print 21 March 2012 , doi:10.1128/CVI.00010-12

  • Comparison of the Long-Term Immunogenicity of Two Pandemic Influenza A/H1N1 2009 Vaccines, the MF59-Adjuvanted and Unadjuvanted Vaccines, in Adults

    • Joon Young Song,
    • Hee Jin Cheong,
    • Yu Bin Seo,
    • In Seon Kim,
    • Ji Yun Noh,
    • Jung Yeon Heo,
    • Won Suk Choi,
    • Jacob Lee,
    • and Woo Joo Kim
    Clin. Vaccine Immunol. May 2012 19:638-641; published ahead of print 29 February 2012 , doi:10.1128/CVI.00026-12

  • Immune Responses and Safety after Dart or Booster Vaccination of Bison with Brucella abortus Strain RB51

    • S. C. Olsen and
    • C. Johnson
    Clin. Vaccine Immunol. May 2012 19:642-648; published ahead of print 29 March 2012 , doi:10.1128/CVI.00033-12

  • DNA and Modified Vaccinia Virus Ankara Vaccines Encoding Multiple Cytotoxic and Helper T-Lymphocyte Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) Are Safe but Weakly Immunogenic in HIV-1-Uninfected, Vaccinia Virus-Naive Adults

    • Geoffrey J. Gorse,
    • Mark J. Newman,
    • Allan deCamp,
    • Christine Mhorag Hay,
    • Stephen C. De Rosa,
    • Elizabeth Noonan,
    • Brian D. Livingston,
    • Jonathan D. Fuchs,
    • Spyros A. Kalams,
    • Farah L. Cassis-Ghavami,
    • and the NIAID HIV Vaccine Trials Network
    Clin. Vaccine Immunol. May 2012 19:649-658; published ahead of print 7 March 2012 , doi:10.1128/CVI.00038-12

  • Analysis of the Bactericidal Response to an Experimental Neisseria meningitidis Vesicle Vaccine

    • Elizabeth E. Moran,
    • Robert Burden,
    • Joseph E. Labrie III,
    • Zhiyun Wen,
    • Xin-Min Wang,
    • Wendell D. Zollinger,
    • Lan Zhang,
    • and Valerian B. Pinto
    Clin. Vaccine Immunol. May 2012 19:659-665; published ahead of print 29 March 2012 , doi:10.1128/CVI.00070-12

  • Induction of Protective Immune Responses by a Multiantigenic DNA Vaccine Encoding GRA7 and ROP1 of Toxoplasma gondii

    • Juan-Hua Quan,
    • Jia-Qi Chu,
    • Hassan Ahmed Hassan Ahmed Ismail,
    • Wei Zhou,
    • Eun-Kyeong Jo,
    • Guang-Ho Cha,
    • and Young-Ha Lee
    Clin. Vaccine Immunol. May 2012 19:666-674; published ahead of print 14 March 2012 , doi:10.1128/CVI.05385-11

  • Cationic Liposomes Extend the Immunostimulatory Effect of CpG Oligodeoxynucleotide against Burkholderia pseudomallei Infection in BALB/c Mice

    • Apichaya Puangpetch,
    • Robert Anderson,
    • Yan Y. Huang,
    • Rasana W. Sermswan,
    • Wanpen Chaicumpa,
    • Stitaya Sirisinha,
    • and Surasakdi Wongratanacheewin
    Clin. Vaccine Immunol. May 2012 19:675-683; published ahead of print 21 March 2012 , doi:10.1128/CVI.05545-11

  • Vaccination with a DNA Vaccine Coding for Perforin-Like Protein 1 and MIC6 Induces Significant Protective Immunity against Toxoplasma gondii

    • Hai-Kuo Yan,
    • Zi-Guo Yuan,
    • Hui-Qun Song,
    • Eskild Petersen,
    • Yang Zhou,
    • Di Ren,
    • Dong-Hui Zhou,
    • Hao-Xin Li,
    • Rui-Qing Lin,
    • Gui-Lian Yang,
    • and Xing-Quan Zhu
    Clin. Vaccine Immunol. May 2012 19:684-689; published ahead of print 29 February 2012 , doi:10.1128/CVI.05578-11

  • Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh

    • Daniel T. Leung,
    • Mohammad Arif Rahman,
    • M. Mohasin,
    • Sweta M. Patel,
    • Amena Aktar,
    • Farhana Khanam,
    • Taher Uddin,
    • M. Asrafuzzaman Riyadh,
    • Amit Saha,
    • Mohammad Murshid Alam,
    • Fahima Chowdhury,
    • Ashraful Islam Khan,
    • Richelle Charles,
    • Regina LaRocque,
    • Jason B. Harris,
    • Stephen B. Calderwood,
    • Firdausi Qadri,
    • and Edward T. Ryan
    Clin. Vaccine Immunol. May 2012 19:690-698; published ahead of print 21 March 2012 , doi:10.1128/CVI.05615-11

  • Modulation of Anti-Tumor Necrosis Factor Alpha (TNF-α) Antibody Secretion in Mice Immunized with TNF-α Kinoid

    • Eric Assier,
    • Luca Semerano,
    • Emilie Duvallet,
    • Laure Delavallée,
    • Emilie Bernier,
    • Marion Laborie,
    • Géraldine Grouard-Vogel,
    • Patrick Larcier,
    • Natacha Bessis,
    • and Marie-Christophe Boissier
    Clin. Vaccine Immunol. May 2012 19:699-703; published ahead of print 21 March 2012 , doi:10.1128/CVI.05649-11

  • CD46 Measles Virus Receptor Polymorphisms Influence Receptor Protein Expression and Primary Measles Vaccine Responses in Naive Australian Children

    • Holly D. Clifford,
    • Catherine M. Hayden,
    • Siew-Kim Khoo,
    • Guicheng Zhang,
    • Peter N. Le Souëf,
    • and Peter Richmond
    Clin. Vaccine Immunol. May 2012 19:704-710; published ahead of print 22 February 2012 , doi:10.1128/CVI.05652-11

  • Improvement of Immunogenicity of Meningococcal Lipooligosaccharide by Coformulation with Lipidated Transferrin-Binding Protein B in Liposomes: Implications for Vaccine Development

    • Noëlle Mistretta,
    • Bruno Guy,
    • Yves Bérard,
    • François Dalençon,
    • Olivia Fratantonio,
    • Christophe Grégoire,
    • Aurélie Lechevallier,
    • Philippe Lhéritier,
    • Laurent Revet,
    • Monique Moreau,
    • Jean Haensler,
    • and Bachra Rokbi
    Clin. Vaccine Immunol. May 2012 19:711-722; published ahead of print 21 March 2012 , doi:10.1128/CVI.05683-11

  • A Novel Tuberculosis DNA Vaccine in an HIV-1 p24 Protein Backbone Confers Protection against Mycobacterium tuberculosis and Simultaneously Elicits Robust Humoral and Cellular Responses to HIV-1

    • Xiaoman Li,
    • Wei Xu,
    • and Sidong Xiong
    Clin. Vaccine Immunol. May 2012 19:723-730; published ahead of print 29 March 2012 , doi:10.1128/CVI.05700-11

  • Analysis of Defined Combinations of Monoclonal Antibodies in Anthrax Toxin Neutralization Assays and Their Synergistic Action

    • Miriam M. Ngundi,
    • Bruce D. Meade,
    • Stephen F. Little,
    • Conrad P. Quinn,
    • Cindi R. Corbett,
    • Rebecca A. Brady,
    • and Drusilla L. Burns
    Clin. Vaccine Immunol. May 2012 19:731-739; published ahead of print 21 March 2012 , doi:10.1128/CVI.05714-11

  • Protection against Lethal Leptospirosis after Vaccination with LipL32 Coupled or Coadministered with the B Subunit of Escherichia coli Heat-Labile Enterotoxin

    • André A. Grassmann,
    • Samuel R. Félix,
    • Carolina Ximendes dos Santos,
    • Marta G. Amaral,
    • Amilton C. P. Seixas Neto,
    • Michel Q. Fagundes,
    • Fabiana K. Seixas,
    • Éverton F. da Silva,
    • Fabricio R. Conceição,
    • and Odir A. Dellagostin
    Clin. Vaccine Immunol. May 2012 19:740-745; published ahead of print 29 February 2012 , doi:10.1128/CVI.05720-11

  • Reduced Frequencies and Heightened CD103 Expression among Virus-Induced CD8+ T Cells in the Respiratory Tract Airways of Vitamin A-Deficient Mice

    • Rajeev Rudraraju,
    • Sherri L. Surman,
    • Bart G. Jones,
    • Robert Sealy,
    • David L. Woodland,
    • and Julia L. Hurwitz
    Clin. Vaccine Immunol. May 2012 19:757-765; published ahead of print 7 March 2012 , doi:10.1128/CVI.05576-11

  • Risk of Invasive Haemophilus influenzae Type b (Hib) Disease in Adults with Secondary Immunodeficiency in the Post-Hib Vaccine Era

    • Eli B. Nix,
    • Nicole Hawdon,
    • Sean Gravelle,
    • Birubi Biman,
    • Malcolm Brigden,
    • Saleem Malik,
    • William McCready,
    • Garry Ferroni,
    • and Marina Ulanova
    Clin. Vaccine Immunol. May 2012 19:766-771; published ahead of print 7 March 2012 , doi:10.1128/CVI.05675-11

Clinical Immunology

  • Heparin-Binding Hemagglutinin Induces IFN-γ+ IL-2+ IL-17+ Multifunctional CD4+ T Cells during Latent but Not Active Tuberculosis Disease

    • André G. Loxton,
    • Gillian F. Black,
    • Kim Stanley,
    • and Gerhard Walzl
    Clin. Vaccine Immunol. May 2012 19:746-751; published ahead of print 29 March 2012 , doi:10.1128/CVI.00047-12

  • Programmed Death 1 Receptor Changes Ex Vivo in HIV-Infected Adults following Initiation of Highly Active Antiretroviral Therapy

    • Sergei Spitsin,
    • Nancy B. Tustin,
    • Eric Riedel,
    • Richard Tustin III,
    • Jennifer B. Murray,
    • Lauren M. Peck,
    • Mohammad Khan,
    • Joseph Quinn,
    • and Steven D. Douglas
    Clin. Vaccine Immunol. May 2012 19:752-756; published ahead of print 21 March 2012 , doi:10.1128/CVI.00093-12

  • Cytomegalovirus-Induced Effector T Cells Cause Endothelial Cell Damage

    • Pablo J. E. J. van de Berg,
    • Si-La Yong,
    • Ester B. M. Remmerswaal,
    • René A. W. van Lier,
    • and Ineke J. M. ten Berge
    Clin. Vaccine Immunol. May 2012 19:772-779; published ahead of print 7 March 2012 , doi:10.1128/CVI.00011-12

  • Hepatitis C Virus-Multispecific T-Cell Responses without Viremia or Seroconversion among Egyptian Health Care Workers at High Risk of Infection

    • Sayed F. Abdelwahab,
    • Zainab Zakaria,
    • Maha Sobhy,
    • Eman Rewisha,
    • Mohamed A. Mahmoud,
    • Mahmoud A. Amer,
    • Mariarosaria Del Sorbo,
    • Stefania Capone,
    • Alfredo Nicosia,
    • Antonella Folgori,
    • Mohamed Hashem,
    • and Samer S. El-Kamary
    Clin. Vaccine Immunol. May 2012 19:780-786; published ahead of print 21 March 2012 , doi:10.1128/CVI.00050-12

  • Microbiological Challenges in the Diagnosis of Chronic Q Fever

    • Linda M. Kampschreur,
    • Jan Jelrik Oosterheert,
    • Annemarie M. C. Koop,
    • Marjolijn C. A. Wegdam-Blans,
    • Corine E. Delsing,
    • Chantal P. Bleeker-Rovers,
    • Monique G. L. De Jager-Leclercq,
    • Cornelis A. R. Groot,
    • Tom Sprong,
    • Marrigje H. Nabuurs-Franssen,
    • Nicole H. M. Renders,
    • Marjo E. van Kasteren,
    • Yvonne Soethoudt,
    • Sybrandus N. Blank,
    • Marjolijn J. H. Pronk,
    • Rolf H. H. Groenwold,
    • Andy I. M. Hoepelman,
    • and Peter C. Wever
    Clin. Vaccine Immunol. May 2012 19:787-790; published ahead of print 21 March 2012 , doi:10.1128/CVI.05724-11

  • Dexamethasone Treatment Has No Effect on the Formation of Pneumococcal Antibodies during Community-Acquired Pneumonia

    • Suzan P. van Mens,
    • Sabine C. A. Meijvis,
    • Jan C. Grutters,
    • Bart J. M. Vlaminckx,
    • Willem J. W. Bos,
    • and Ger T. Rijkers
    Clin. Vaccine Immunol. May 2012 19:811-813; published ahead of print 29 February 2012 , doi:10.1128/CVI.05697-11

Diagnostic Laboratory Immunology

  • Performance of the QuantiFERON-Cytomegalovirus (CMV) Assay for Detection and Estimation of the Magnitude and Functionality of the CMV-Specific Gamma Interferon-Producing CD8+ T-Cell Response in Allogeneic Stem Cell Transplant Recipients

    • María Ángeles Clari,
    • Beatriz Muñoz-Cobo,
    • Carlos Solano,
    • Isabel Benet,
    • Elisa Costa,
    • María José Remigia,
    • Dayana Bravo,
    • Paula Amat,
    • and David Navarro
    Clin. Vaccine Immunol. May 2012 19:791-796; published ahead of print 29 February 2012 , doi:10.1128/CVI.05633-11

  • Specificity of the Tuberculin Skin Test Is Modified by Use of a Protein Cocktail Containing ESAT-6 and CFP-10 in Cattle Naturally Infected with Mycobacterium bovis

    • S. Flores-Villalva,
    • F. Suárez-Güemes,
    • C. Espitia,
    • A. O. Whelan,
    • M. Vordermeier,
    • and J. A. Gutiérrez-Pabello
    Clin. Vaccine Immunol. May 2012 19:797-803; published ahead of print 14 March 2012 , doi:10.1128/CVI.05668-11

  • Comparison of Seven Commercial Antigen and Antibody Enzyme-Linked Immunosorbent Assays for Detection of Acute Dengue Infection

    • Stuart D. Blacksell,
    • Richard G. Jarman,
    • Robert V. Gibbons,
    • Ampai Tanganuchitcharnchai,
    • Mammen P. Mammen Jr.,
    • Ananda Nisalak,
    • Siripen Kalayanarooj,
    • Mark S. Bailey,
    • Ranjan Premaratna,
    • H. Janaka de Silva,
    • Nicholas P. J. Day,
    • and David G. Lalloo
    Clin. Vaccine Immunol. May 2012 19:804-810; published ahead of print 21 March 2012 , doi:10.1128/CVI.05717-11
    OPEN ACCESS ARTICLE

  • Humoral Immune Responses in a Human Case of Glanders

    • David M. Waag,
    • Marilyn J. England,
    • and David DeShazer
    Clin. Vaccine Immunol. May 2012 19:814-816; published ahead of print 7 March 2012 , doi:10.1128/CVI.05567-11

  • New Enzyme-Linked Immunosorbent Assay for Detection of Antibodies against Hepatitis Delta Virus Using a Hepatitis Delta Antigen Derived from a Taiwanese Clone and Comparison to the Abbott Radioimmunoassay

    • Yung-Bin Kuo,
    • Mei Chao,
    • Yi-Hsuan Lee,
    • Chau-Ting Yeh,
    • and Err-Cheng Chan
    Clin. Vaccine Immunol. May 2012 19:817-819; published ahead of print 7 March 2012 , doi:10.1128/CVI.05687-11

Case Report

  • False-Negative Hepatitis B Virus (HBV) Surface Antigen in a Vaccinated Dialysis Patient with a High Level of HBV DNA in the United States

    • Matthew C. Foy,
    • Chloe L. Thio,
    • Hyon S. Hwang,
    • Melissa Saulynas,
    • James P. Hamilton,
    • Derek M. Fine,
    • and Mohamed G. Atta
    Clin. Vaccine Immunol. May 2012 19:820-822; published ahead of print 21 March 2012 , doi:10.1128/CVI.05696-11

Letter to the Editor

  • Interleukin-12 (IL-12)/IL-10 Ratio as a Marker of Disease Severity in Crimean-Congo Hemorrhagic Fever

    • Dionysios C. Watson,
    • Maria Sargianou,
    • and George Panos
    Clin. Vaccine Immunol. May 2012 19:823-824; doi:10.1128/CVI.00030-12

This Issue

May 2012, volume 19, issue 5
Cover
Other Issues

Section Links

  1. Vaccines
  2. Clinical Immunology
  3. Diagnostic Laboratory Immunology
  4. Case Report
  5. Letter to the Editor

Find articles in this issue containing these words:

current issue

    May 2012, volume 19, issue 5
  1. Current Issue
  1. Alert me to new issues of CVI